[144] Arteris, Inc. SEC Filing

Rhea-AI Filing Summary

Arteris, Inc. (AIP) Form 144 filing: insider entities led by K. Charles Janac intend to sell 94,245 common shares on or about 08/05/2025 through Morgan Stanley Smith Barney. At the stated price this equals $890,615.25 and represents roughly 0.22 % of the 41,977,728 shares outstanding.

The shares were originally acquired on 06/16/2014 in a private, cash-paid transaction with the issuer. The filer affirms no undisclosed adverse information.

Recent activity: Over the last three months the same account sold 43,557 shares across six Rule 10b5-1 trades, generating $410,078.18 in gross proceeds (largest block: 18,620 shares on 06/27/2025).

• No operational or earnings data is included; the document is solely a notice of proposed insider sales.

Insights

Securities Analyst

TL;DR: Small (<0.3 %) insider sale; signals liquidity event more than strategic shift; limited market impact.

The planned disposition of 94,245 shares equals just 0.22 % of outstanding stock, so supply overhang is modest. Prior 10b5-1 activity indicates a consistent selling cadence—43,557 shares already sold in the last quarter—suggesting a diversification motive rather than sudden pessimism. Because the sale is pre-arranged, transparent, and accompanied by a no-MNPI representation, I view market impact as low and sentiment as slightly negative but largely neutral for valuation.

Corporate Governance Expert

TL;DR: Continued insider selling warrants monitoring; governance disclosure remains compliant.

Management’s use of Rule 144 and 10b5-1 plans adheres to best-practice disclosure standards. Nonetheless, recurring sales by the CEO and affiliated LLC may raise perception risk among investors who equate insider selling with diminished confidence. Given the small percentage of shares and transparent filing, I classify the governance impact as limited yet worth watching if the pattern accelerates.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	94245	890615.25	41977728	08/05/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/16/2014	Private Acquisition from Issuer or an Affiliate	Issuer			94245	06/16/2014	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for K. CHARLES JANAC 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	07/03/2025	11815	109230.86
K. CHARLES JANAC 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	07/02/2025	7153	64322.64
10b5-1 Sales for K. CHARLES JANAC 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	07/01/2025	2666	24238.74
10b5-1 Sales for BAYVIEW LEGACY, LLC 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	06/27/2025	18620	186585.43
10b5-1 Sales for K. CHARLES JANAC 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	COMMON	06/04/2025	2057	16102.20
K. CHARLES JANAC 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	COMMON	06/02/2025	1246	9598.31

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many Arteris (AIP) shares are insiders planning to sell?

94,245 common shares are scheduled for sale on or about 08/05/2025.

What is the market value of the proposed AIP insider sale?

The aggregate market value disclosed is $890,615.25.

How does the planned sale compare to shares outstanding for AIP?

It represents roughly 0.22 % of the 41,977,728 shares outstanding.

Have there been recent insider sales at Arteris?

Yes, six 10b5-1 transactions between 06/02/2025-07/03/2025 disposed of 43,557 shares for $410,078.18.

When were the shares originally acquired by the insider?

The shares were purchased on 06/16/2014 via a private, cash transaction with the issuer.

Which broker will execute the sale?

Morgan Stanley Smith Barney LLC, Executive Financial Services, New York.